Aron Roxin, Ph.D. - Publications

Affiliations: 
2014 Pharmaceutical Sciences University of Toronto, Toronto, ON, Canada 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lepage ML, Kuo HT, Roxin A, Huh S, Zhang Z, Kandasamy RL, Merkens H, Kumlin J, Limoges A, Zeisler SK, Benard F, Lin KS, Perrin D. Toward 18F-Labeled Theranostics: A Single Agent that can be Labeled with 18F, 64Cu, or 177Lu. Chembiochem : a European Journal of Chemical Biology. PMID 31621172 DOI: 10.1002/Cbic.201900632  0.327
2019 Roxin A, Zhang C, Huh S, Lepage ML, Zhang Z, Lin KS, Bénard F, Perrin DM. A Metal-Free DOTA-Conjugated 18F-Labeled Radiotracer: [18F]DOTA-AMBF3-LLP2A for Imaging VLA-4 Over-Expression in Murine Melanoma with Improved Tumor Uptake and Greatly Enhanced Renal Clearance. Bioconjugate Chemistry. PMID 30896929 DOI: 10.1021/Acs.Bioconjchem.9B00146  0.337
2019 Kuo HT, Lepage M, Lin KS, Pan J, Zhang Z, Liu Z, Pryyma A, Zhang C, Merkens H, Roxin A, Perrin D, Benard F. One-step F-labeling and preclinical evaluation of prostate specific membrane antigen trifluoroborate probes for cancer imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30737299 DOI: 10.2967/Jnumed.118.216598  0.333
2018 Roxin Á, Zhang C, Huh S, Lepage ML, Zhang Z, Lin KS, Bénard F, Perrin DM. Preliminary evaluation ofF-labeled LLP2A-trifluoroborate conjugates as VLA-4 (αβintegrin) specific radiotracers for PET imaging of melanoma. Nuclear Medicine and Biology. 61: 11-20. PMID 29597141 DOI: 10.1016/J.Nucmedbio.2018.02.005  0.319
2016 Walker D, Li Y, Roxin Á, Schaffer P, Adam MJ, Perrin DM. Facile synthesis and (18)F-radiolabeling of α4β1-specific LLP2A-aryltrifluoroborate peptidomimetic conjugates. Bioorganic & Medicinal Chemistry Letters. PMID 27623550 DOI: 10.1016/J.Bmcl.2016.08.011  0.358
2015 Farhadi A, Roxin Á, Wilson BC, Zheng G. Nano-enabled SERS reporting photosensitizers. Theranostics. 5: 469-76. PMID 25767614 DOI: 10.7150/Thno.10694  0.467
2014 Ng KK, Shakiba M, Huynh E, Weersink RA, Roxin Á, Wilson BC, Zheng G. Stimuli-responsive photoacoustic nanoswitch for in vivo sensing applications. Acs Nano. 8: 8363-73. PMID 25046406 DOI: 10.1021/Nn502858B  0.531
2014 Luby BM, Farhadi A, Shakiba M, Charron DM, Roxin A, Zheng G. Research Highlights: highlights from the latest articles in nanomedicine. Nanomedicine (London, England). 9: 385-8. PMID 24787437 DOI: 10.2217/Nnm.13.216  0.332
2014 Roxin Á, Chen J, Paton AS, Bender TP, Zheng G. Modulation of reactive oxygen species photogeneration of bacteriopheophorbide a derivatives by exocyclic E-ring opening and charge modifications. Journal of Medicinal Chemistry. 57: 223-37. PMID 24328124 DOI: 10.1021/Jm401538H  0.392
2014 Roxin A, MacDonald TD, Zheng G. Synthesis and characterization of a new natural product analog, 13 2-173-bacteriochlorophyllone a Journal of Porphyrins and Phthalocyanines. 18: 188-199. DOI: 10.1142/S1088424613501058  0.401
2012 Roxin Á, Zheng G. Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides. Future Medicinal Chemistry. 4: 1601-18. PMID 22917248 DOI: 10.4155/Fmc.12.75  0.406
2012 Roxin Á, Chen J, Scully CC, Rotstein BH, Yudin AK, Zheng G. Conformational modulation of in vitro activity of cyclic RGD peptides via aziridine aldehyde-driven macrocyclization chemistry. Bioconjugate Chemistry. 23: 1387-95. PMID 22709546 DOI: 10.1021/Bc300239A  0.449
2011 Lovell JF, Roxin A, Ng KK, Qi Q, McMullen JD, DaCosta RS, Zheng G. Porphyrin-cross-linked hydrogel for fluorescence-guided monitoring and surgical resection. Biomacromolecules. 12: 3115-8. PMID 21777008 DOI: 10.1021/Bm200784S  0.553
Show low-probability matches.